-
Something wrong with this record ?
The development of a high-affinity conformation-sensitive antibody mimetic using a biocompatible copolymer carrier (iBody)
K. Blažková, J. Beranová, M. Hradilek, L. Kostka, V. Šubr, T. Etrych, P. Šácha, J. Konvalinka
Language English Country United States
Document type Journal Article, Research Support, Non-U.S. Gov't
NLK
Directory of Open Access Journals
from 2021
Free Medical Journals
from 2008 to 1 year ago
Freely Accessible Science Journals
from 1905 to 1 year ago
PubMed Central
from 2005
Europe PubMed Central
from 2005 to 1 year ago
Open Access Digital Library
from 1905-10-01
Open Access Digital Library
from 1905-10-01
ROAD: Directory of Open Access Scholarly Resources
from 1905
- MeSH
- Biomimetic Materials chemistry MeSH
- Kallikreins chemistry MeSH
- Humans MeSH
- Drug Carriers chemistry MeSH
- Peptide Library * MeSH
- Prostate-Specific Antigen chemistry MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
Peptide display methods are a powerful tool for discovering new ligands of pharmacologically relevant targets. However, the selected ligands often suffer from low affinity. Using phage display, we identified a new bicyclic peptide binder of prostate-specific membrane antigen (PSMA), a metalloprotease frequently overexpressed in prostate cancer. We show that linking multiple copies of a selected low-affinity peptide to a biocompatible water-soluble N-(2-hydroxypropyl)methacrylamide copolymer carrier (iBody) improved binding of the conjugate by several orders of magnitude. Furthermore, using ELISA, enzyme kinetics, confocal microscopy, and other approaches, we demonstrate that the resulting iBody can distinguish between different conformations of the target protein. The possibility to develop stable, fully synthetic, conformation-selective antibody mimetics has potential applications for molecular recognition, diagnosis and treatment of many pathologies. This strategy could significantly contribute to more effective drug discovery and design.
1st Medical Faculty Charles University Prague Czech Republic
Institute of Macromolecular Chemistry Czech Academy of Sciences Prague Czech Republic
Institute of Organic Chemistry and Biochemistry Czech Academy of Sciences Prague Czech Republic
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22003316
- 003
- CZ-PrNML
- 005
- 20220127150341.0
- 007
- ta
- 008
- 220113s2021 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.jbc.2021.101342 $2 doi
- 035 __
- $a (PubMed)34710374
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Blažková, Kristyna $u Institute of Organic Chemistry and Biochemistry, Czech Academy of Sciences, Prague, Czech Republic; Department of Cell and Developmental Biology, Faculty of Science, Charles University, Prague, Czech Republic
- 245 14
- $a The development of a high-affinity conformation-sensitive antibody mimetic using a biocompatible copolymer carrier (iBody) / $c K. Blažková, J. Beranová, M. Hradilek, L. Kostka, V. Šubr, T. Etrych, P. Šácha, J. Konvalinka
- 520 9_
- $a Peptide display methods are a powerful tool for discovering new ligands of pharmacologically relevant targets. However, the selected ligands often suffer from low affinity. Using phage display, we identified a new bicyclic peptide binder of prostate-specific membrane antigen (PSMA), a metalloprotease frequently overexpressed in prostate cancer. We show that linking multiple copies of a selected low-affinity peptide to a biocompatible water-soluble N-(2-hydroxypropyl)methacrylamide copolymer carrier (iBody) improved binding of the conjugate by several orders of magnitude. Furthermore, using ELISA, enzyme kinetics, confocal microscopy, and other approaches, we demonstrate that the resulting iBody can distinguish between different conformations of the target protein. The possibility to develop stable, fully synthetic, conformation-selective antibody mimetics has potential applications for molecular recognition, diagnosis and treatment of many pathologies. This strategy could significantly contribute to more effective drug discovery and design.
- 650 _2
- $a biomimetické materiály $x chemie $7 D040761
- 650 _2
- $a nosiče léků $x chemie $7 D004337
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a kalikreiny $x chemie $7 D007610
- 650 12
- $a peptidová knihovna $7 D019151
- 650 _2
- $a prostatický specifický antigen $x chemie $7 D017430
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Beranová, Jana $u Institute of Organic Chemistry and Biochemistry, Czech Academy of Sciences, Prague, Czech Republic; First Medical Faculty, Charles University, Prague, Czech Republic
- 700 1_
- $a Hradilek, Martin $u Institute of Organic Chemistry and Biochemistry, Czech Academy of Sciences, Prague, Czech Republic
- 700 1_
- $a Kostka, Libor $u Institute of Macromolecular Chemistry, Czech Academy of Sciences, Prague, Czech Republic
- 700 1_
- $a Šubr, Vladimír $u Institute of Macromolecular Chemistry, Czech Academy of Sciences, Prague, Czech Republic
- 700 1_
- $a Etrych, Tomáš $u Institute of Macromolecular Chemistry, Czech Academy of Sciences, Prague, Czech Republic
- 700 1_
- $a Šácha, Pavel $u Institute of Organic Chemistry and Biochemistry, Czech Academy of Sciences, Prague, Czech Republic. Electronic address: pavelsacha@gmail.com
- 700 1_
- $a Konvalinka, Jan $u Institute of Organic Chemistry and Biochemistry, Czech Academy of Sciences, Prague, Czech Republic; Department of Cell and Developmental Biology, Faculty of Science, Charles University, Prague, Czech Republic. Electronic address: jan.konvalinka@uochb.cas.cz
- 773 0_
- $w MED00002546 $t The Journal of biological chemistry $x 1083-351X $g Roč. 297, č. 5 (2021), s. 101342
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/34710374 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20220113 $b ABA008
- 991 __
- $a 20220127150337 $b ABA008
- 999 __
- $a ok $b bmc $g 1750933 $s 1154465
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2021 $b 297 $c 5 $d 101342 $e 20211025 $i 1083-351X $m The Journal of biological chemistry $n J Biol Chem $x MED00002546
- LZP __
- $a Pubmed-20220113